Bacitracin EP Impurity P
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Bacitracin EP Impurity P

● In Stock

Catalogue No.:VE0026831
CAS No.:N/A
Mol. Formula:C66H103N17O16S
Mol. Weight:1422.70 g/mol

Additional information on

Parent drug

Bacitracin

IUPAC Name

Mil = 5- methylene-L-isoleucine:4,10-Anhydro[N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazol-4-yl]carbonyl]-L-leucyl-D-α-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-5-methylene-L-isoleucyl-D-phenylalanyl-L-histidyl-D-α-aspartyl-L-asparagine]

Pharmacopeial Synonyms

Bacitracin J2

Synonyms

N/A

Description

Bacitracin EP Impurity P, also designated Bacitracin J2, is a closely related cyclic dodecapeptide impurity associated with the bacitracin complex, arising primarily from biosynthetic microheterogeneity and peptide-chain variation during fermentation or subsequent purification. With molecular formula C66H103N17O16S and molecular weight 1422.70 g/mol, it contains the characteristic thiazoline-containing peptide architecture of bacitracin species and differs from the principal components by subtle sequence and oxidation-state features. Its characterization typically requires orthogonal RP-HPLC, LC-MS/MS, and high-resolution mass spectrometry, with peptide mapping or tandem fragmentation used to confirm identity and relative abundance in pharmacopeial impurity profiles.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url